Patent · US Active

Anti-IL-23 antibodies, compositions, methods and uses

US10272152B2 · kind B2 · utility

1Cited by
22References
11Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJun 19, 2017
Grant dateApr 30, 2019
Priority date
Expiry dateJun 19, 2037

Classification

  • Technology area (CPC Y)Emerging Cross-Sectional Technologies
  • CPC primaryY02A50/30
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

An anti-IL-23 antibody, including isolated nucleic acids that encode at least one anti-IL-23 antibody, vectors, host cells, transgenic animals or plants, and methods of making and using thereof have applications in diagnostic and/or therapeutic compositions, methods and devices.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.